Immunovant, Inc. 4

On 2026-08-28, insider Atul Pande exercised 1,500 Immunovant, Inc. stock options at $8.43 and sold 1,500 common shares at $43.27 under a Rule 10b5-1 plan.

On August 28, 2026, Immunovant, Inc. insider Atul Pande exercised 1,500 stock options at $8.43 per share, acquiring 1,500 shares of common stock for approximately $12,645, and on the same day sold 1,500 shares of common stock at $43.27 per share for proceeds of approximately $64,905 under a Rule 10b5-1 trading plan. Following these transactions, his directly held common stock position decreased modestly from 118,231 to 116,731 shares, and he also reports an additional 20,000 shares held indirectly by trust, while 1,500 stock options at a $8.43 strike remain outstanding until November 19, 2029. The form notes that the options are fully vested and that the sale was effected pursuant to the pre-established trading plan, suggesting a routine liquidity/portfolio management transaction rather than a new directional bet.

Filing Facts

CIK

1764013

Ticker

IMVT

Form

4

Source Type

fda

Accession

0001764013-26-000103

Alert Tier

6